Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
ANTI-CANCER DRUGS
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model
. 21:861-867.
2010
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer
. 17:697-704.
2006
Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients
. 9:611-619.
1998
Identity
International Standard Serial Number (ISSN)
0959-4973
Electronic International Standard Serial Number (EISSN)
1473-5741
Other
journal abbreviation
ANTI-CANCER DRUG